Is CNCE A Good Stock To Buy Now?
After several tireless days we have finished crunching the numbers from nearly 817 13F filings issued by the elite hedge funds and other investment firms that we track at Insider Monkey, which disclosed...
Concert Pharmaceuticals Inc. (CNCE)
Get Email AlertsSector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value (x$1000) | Activity | % Port |
|---|---|---|---|---|---|
| 1. | RA Capital Management Peter Kolchinsky | 3,033,603 | $10,223 | 0.22% | |
| 2. | Biotechnology Value Fund / BVF Inc Mark Lampert | 2,253,000 | $7,593 | 0.3% | |
| 3. | Perceptive Advisors Joseph Edelman | 2,150,641 | $7,247 | 0.14% | |
| 4. | Millennium Management Israel Englander | 1,245,412 | $4,197 | -8% | 0% |
| 5. | Alyeska Investment Group Anand Parekh | 548,090 | $1,847 | 0.02% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $8.52 | 1,500 | Director | 6,500 | 2020-03-12 | Filing | |
| $10.91 | 1,000 | Director | 5,000 | 2020-02-03 | Filing | |
| $5.90 | 5,000 | Director | 10,000 | 2019-10-08 | Filing | |
| $10.84 | 5,000 | Director | 5,000 | 2019-08-02 | Filing | |
| $11.50 | 1,000 | Director | 4,000 | 2018-11-15 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $3.09 | 13,480 | Officer, Director | 980,258 | 2022-02-15 | Filing | |
| $3.08 | 6,049 | Officer | 284,737 | 2022-02-14 | Filing | |
| $3.09 | 3,762 | Officer | 103,197 | 2022-02-14 | Filing | |
| $3.09 | 3,762 | Officer | 189,822 | 2022-02-14 | Filing | |
| $3.08 | 3,762 | Officer | 139,011 | 2022-02-14 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value (x$1000) | % Port |
|---|---|---|---|---|
| 1. | 1,317,423 | $4,440 | 0.19% | |
| 2. | 1,006,959 | $3,393 | 0% | |
| 3. | 878,161 | $2,960 | 0% | |
| 4. | 794,106 | $2,675 | 0.01% | |
| 5. | 778,596 | $2,624 | 0% |
News See All
Hedge Fund Sentiment Is Stagnant On Concert Pharmaceuticals Inc (CNCE)
At the end of February we announced the arrival of the first US recession since 2009 and we predicted that the market will decline by at least 20% in (see why hell is coming).
Hedge Fund and Insider Trading News: EJF Capital, Man Group, Bridgewater Associates, Natera Inc (NTRA), Kinross Gold Corporation (KGC), and More
EJF Capital, which saw substantial losses amid the coronavirus-related selloff in March, is raising capital for a fund that seeks to take advantage of fresh opportunities it sees in the unsettled financial...
Do Hedge Funds Love Concert Pharmaceuticals Inc (CNCE)?
Concerns over rising interest rates and expected further rate increases have hit several stocks hard during the fourth quarter of 2018.
Concert Pharmaceuticals Inc (CNCE) Is Burning These Hedge Funds
Amid an overall bull market, many stocks that smart money investors were collectively bullish on surged through October 17th.
Do Hedge Funds Love Concert Pharmaceuticals Inc (CNCE)?
Concerns over rising interest rates and expected further rate increases have hit several stocks hard since the end of the third quarter.
Market Movers Today: Facebook Inc (FB), Kohl’s Corporation (KSS), GameStop Corp. (GME) and More
One Wall Street analyst abruptly changed his view for Facebook shares within hours after seeing a big drop in the internet giant's stock price.
Here’s What A Concert Pharmaceuticals Inc (CNCE) Data Win Might Mean For The Company
The final six months 2015, and pretty much the entirety of 2016, proved a tough period for the majority of biotechnology companies.
How Concert Pharmaceuticals Inc (CNCE) Stacks Up Against Its Peers
A whopping number of 13F filings filed with U.S.
Noteworthy Insider Buying and Selling at MiMedx Group, Aetna & Others
It is generally believed that insider buying and selling metrics can provide clues about companies’ future stock price direction.
Billionaire Hedge Funds
